<DOC>
	<DOCNO>NCT02458469</DOCNO>
	<brief_summary>The purpose study look effect excite use drug target specific pathway body , rely natural chemical body produce call 'serotonin ' , patient spinal cord injury ( SCI ) sleep . During part study participant ask take buspirone ( Buspar ) ( 15-50mg per day ) , trazodone ( 100mg per day ) placebo random fashion , 2 week period ( drug period ) time follow two week without drug ( washout period ) . The drug take time , take separately two week follow night study look effect medication/placebo pill way body respond sleep .</brief_summary>
	<brief_title>Role Enhancing Serotonin Receptors Activity Sleep Apnea Treatment Patients With SCI</brief_title>
	<detailed_description>Randomized placebo control cross-over study . Each subject study three separate occasion : ( 1 ) Buspirone vs. Trazodone vs. placebo 2 week ; patient blind whether take trazodone placebo ; buspirone blind dosed twice day titrate two week administration . The initial dose Buspirone 15 mg daily ( 7.5 mg bid. ) . To achieve optimal therapeutic response , interval 2 3 day dosage may increase 5 mg per day maximum dose 30mg/day reach . After two week treatment sleep study repeat . Trazodone give 100 mg dose bed-time . ( 2 ) Cross medication two week follow second sleep study follow two week washout . ( 3 ) Cross medication two week follow another sleep study . To assess clinical effect drug breathe sleep qualitative polysomnography perform 2 hour night take drug/placebo . This allow determination ventilatory change determination number respiratory event ( apnea/hypopnea index ) .</detailed_description>
	<mesh_term>Spinal Cord Injuries</mesh_term>
	<mesh_term>Respiratory Aspiration</mesh_term>
	<mesh_term>Buspirone</mesh_term>
	<mesh_term>Trazodone</mesh_term>
	<criteria>Adults SCI ( &gt; 6months spinal cord injury ) T6 level/above Pregnant lactating female Demyelinating SCI Heart failure , vascular disease , stroke History head trauma &gt; loss consciousness &gt; 24h Advanced chronic obstructive pulmonary disease ( COPD ) , liver disease , chronic kidney disease BMI &gt; 38 kg/m2 Blood pressure rest &gt; 160 /95 mmHg Mechanical ventilation dependence The following medication allow ( potential interaction buspirone inhibition CYP3A4 system ) : cimetidine ketoconazole ritonavir itraconazole erythromycin diltiazem verapamil Monoamine oxidase ( MAO ) inhibitor [ Marplan , Nardil , Parmate , Emsam ] Other prohibit concomitant medication include haloperidol , trazodone , triazolam</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>